The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Hintergrund Der Stellenwert eines auf dem prostataspezifischen Antigen (PSA) basierten Screenings wird kontrovers beurteilt. Auf der einen Seite zeigt sich durch ein PSA-Screening ein Überlebensvorteil hinsichtlich der tumorspezifischen Mortalität, der mit längerer Nachbeobachtungszeit zunimmt. Auf der anderen Seite existieren mögliche Einschränkungen wie Überdiagnostik/-therapie und therapiebedingte...
Purpose The American Urological Association (AUA) published new prostate cancer (CaP) screening guidelines in 2013. We apply the guidelines to a retrospective cohort to compare tumor characteristics of those no longer recommended for screening with those who remain screening candidates. Methods We identified cases of screening detected CaP (stage cT1c) in the Surveillance Epidemiology and End Results...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.